The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate CancerNeil J. Shah, William Oh, Jones T. Nauseef et al.|JNCI Cancer Spectrum|2022Cited by 11
The role of androgen deprivation therapy on the clinical course of COVID-19 infection in men with prostate cancer.Vaibhav G. Patel, William Oh, Xiaobo Zhong et al.|Journal of Clinical Oncology|2021Cited by 5
Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor–targeted TherapyZakaria Chakrani, Vaibhav G. Patel, Nathaniel Saffran et al.|American Journal of Clinical Oncology|2024Cited by 2
Performance Status and End-of-Life Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Androgen Receptor Targeted TherapyGeorge Mellgard, Vaibhav G. Patel, Nathaniel Saffran et al.|American Journal of Clinical Oncology|2024Cited by 2
Performance status and end-of-life outcomes in patients with metastatic castration resistant prostate cancer treated with androgen receptor targeted therapyGeorge Mellgard, Vaibhav G. Patel, Nathaniel Saffran et al.|Research Square|2023Cited by 1